In vivo and in vitro efficacy of an acid-sensitive albumin conjugate of adriamycin compared to the parent compound in murine renal-cell carcinoma

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 6, Issue 2, 1999, Pages 89-95

  Drevs, Joachim ^a   Hofmann, Inga ^a   Marmé, Dieter ^a   Unger, Clemens ^a   Kratz, Felix ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

Author keywords

Adriamycin; Antitumor activity; Human serum albumin; Murine renal cell carcinoma; Protein conjugates

Indexed keywords

ALBUMIN CONJUGATE; DOXORUBICIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG STRUCTURE; FEMALE; KIDNEY CARCINOMA; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REMISSION;

EID: 0033067973     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/107175499267002     Document Type: Article

References (17)

1. Greenfield, R. S., T. Kaneko, A. Daues, M. A. Edson, K. A. Fitzgerald, L. J. Olech, A. Grattan, G. L. Spitalny, and G. R. Braslawsky. 1990. In vitro evaluation of Adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker. Cancer Res. 50:6600-6607.
2. Hillman, G. G., J. Droz, and G. H. Haas. 1994. Experimental animal models for the study of therapeutic approaches in renal cell carcinoma. In Vivo 8:77-80.
3. Kratz, F., M. Hartmann, B. K. Keppler, and L. Messori. 1994. The binding properties of two antitumor ruthenium(III) complexes to apotransferrin. J. Biol. Chem. 269:2581-2588.
4. Kratz, F., U. Beyer, M. Krüger, P. Schumacher, H. Zahn, T. Roth, H. H. Fiebig, and C. Unger. 1997a. Synthesis of new maleimide derivatives of daunorubicin and biological activity of acid labile transferrin conjugates. Biorg. Med. Chem. Lett. 7:617-622.
5. Kratz, F., I. Fichtner, U. Beyer, P. Schumacher, T. Roth, H. H. Fiebig, and C. Unger. 1997b. Antitumour activity of acid labile transferrin and albumin doxorubicin conjugates in in vitro and in vivo human tumor xenograft models. Eur. J. Cancer 33(suppl. 8):S175.
6. Kratz, F., U. Beyer, P. Collery, F. Lechenault, A. Cazabat, P. Schumacher, U. Falken, and C. Unger. 1998a. Preparation, characterization and in vitro efficacy of albumin conjugates of doxorubicin. Biol. Pharm. Bull. 21:56-61.
7. Kratz, F., U. Beyer, T. Roth, N. Tarasova, P. Collery, F. Lechenault, A. Cazabat, P. Schumacher, C. Unger, and U. Falken. 1998b. Transferrin conjugates of doxorubicin: Synthesis, characterization, cellular uptake, and in vitro efficacy. J. Pharm. Sci. 87:338-346.
8. Kratz, F., T. Roth, I. Fichtner, H. H. Fiebig, and C. Unger. 1998c. Development of antitumor protein and polymer conjugates using in vitro and in vivo tumor xenograft models. In Relevance of tumor models for anticancer drug development, Contribution to oncology, 27 ed. H. H. Fiebig. Basel: Karger Verlag.
9. Maeda, H., and Y. Matsumura. 1989. Tumoritropic and lymphotropic principles of macromolecular prodrugs. Crit. Rev. Ther. Drug Carrier Sys. 6:193-210.
10. Mancilla-Jimenez, R. 1976. Papillary renal cell carcinoma: A clinical, radiological and pathological study of 34 cases. Cancer 38:2466-2469.
11. Matsumura, Y., and H. Maeda. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins of the antitumor agent smancs. Cancer Res. 46:6387-6392.
12. Salup, R. R., and R. H. Wiltrout. 1986. Adjuvant immunotherapy of established murine renal cancer by interleukin 2 stimulated cytotoxic lymphocytes. Cancer Res. 46:3358-3363.
13. Sands, H., P. L. Jones, A. S. Shah, D. Palme, R. L. Vessella, and B. M. Gallagher. 1988. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human clouse and renal cell xenografts. Cancer Res. 48:188-193.
14. Sayers, T. J., T. A. Wiltrout, K. McCormick, C. Husted, and R. H. Wiltrout. 1990. Antitumor effects of α-interferon and γ-interferon on a murine renal cancer (Renca) in vitro and in vivo. Cancer Res. 50:5414-5420.
15. Schüler, J., H. H. Fiebig, E. A. Sausville, and A. M. Burger. 1997. Characterization of vascular permeability in human tumor xenografts - Identification of suitable tumor models to evaluate polymer conjugates. Int. Symp. Relevance of Tumor Models for Anticancer Drug Development, p. 6, 15-17 October, Tumor Biology Center, Freiburg, FRG.
16. Sinn, H., H. H. Schrenk, A. Friedrich, U. Schilling, and W. Maier-Borst. 1990. Design of compounds having an enhanced tumour uptake, using serum albumin as a carrier. Part 1. Nucl. Med. Biol. 17(Int. J. Rad. Appl. Instrum. B):819-827.
17. Takakura, Y., T. Fujita, M. Hashida, and H. Sezaki. 1990. Disposition characteristics of macromolecules in tumor-bearing mice. Pharm. Res. 7:339-346.